Henrik Palmgren

Henrik Palmgren

Auto-generated profile, based on publicly available information

Henrik Palmgren

Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Drug Metabolism and Disposition
Verified
Journal Article
Open access
PDF file
CBCatherine C. Bell
Catherine C. Bell
VLVolker Lauschke
Volker Lauschke
SVSabine U. Vorrink
Sabine U. Vorrink
HPHenrik Palmgren
Henrik Palmgren
RDRodger Duffin
Rodger Duffin
MIMagnus Ingelman-Sundberg
Magnus Ingelman-Sundberg
Reliable and versatile hepatic in vitro systems for the prediction of drug pharmacokinetics and toxicity are essential constituents of preclinical safety assessment pipelines for new medicines. Here, we compared three emerging cell systems—hepatocytes derived from induced pluripotent stem cells, HepaRG cells, and three-dimensional primary human hepatocyte (PHH) spheroids—at transcriptional and functional levels in a multicenter study to evaluate their potential as predictive models for drug-induced hepatotoxicity. Transcriptomic analyses revealed widespread gene expression differences between the three cell models, with 8148 of 17,462 analyzed genes (47%) being differentially expressed. Expression levels of genes involved in the metabolism of endogenous as well as xenobiotic compounds were significantly elevated in PHH spheroids, whereas genes involved in cell division and endocytosis were significantly upregulated in HepaRG cells and hepatocytes derived from induced pluripotent stem cells, respectively. Consequently, PHH spheroids were more sensitive to a panel of drugs with distinctly different toxicity mechanisms, an effect that was amplified by long-term exposure using repeated treatments. Importantly, toxicogenomic analyses revealed that transcriptomic changes in PHH spheroids were in compliance with cholestatic, carcinogenic, or steatogenic in vivo toxicity mechanisms at clinically relevant drug concentrations. Combined, the data reveal important phenotypic differences between the three cell systems and suggest that PHH spheroids can be used for functional investigations of drug-induced liver injury in vivo in humans.

1 December 2018 in Kidney International
Verified
Journal Article
Open access
CBCecilia Boreström
Cecilia Boreström
AJAnna Jonebring
Anna Jonebring
JGJing Guo
Jing Guo
HPHenrik Palmgren
Henrik Palmgren
LCLinda Cederblad
Linda Cederblad
ACAnna Collén
Anna Collén
Development of physiologically relevant cellular models with strong translatability to human pathophysiology is critical for identification and validation of novel therapeutic targets. Herein we describe a detailed protocol for generation of an advanced 3-dimensional kidney cellular model using induced pluripotent stem cells, where differentiation and maturation of kidney progenitors and podocytes can be monitored in live cells due to CRISPR/Cas9-mediated fluorescent tagging of kidney lineage markers (SIX2 and NPHS1). Utilizing these cell lines, we have refined the previously published procedures to generate a new, higher throughput protocol suitable for drug discovery. Using paraffin-embedded sectioning and whole-mount immunostaining, we demonstrated that organoids grown in suspension culture express key markers of kidney biology (WT1, ECAD, LTL, nephrin) and vasculature (CD31) within renal cortical structures with microvilli, tight junctions and podocyte foot processes visualized by electron microscopy. Additionally, the organoids resemble the adult kidney transcriptomics profile, thereby strengthening the translatability of our in vitro model. Thus, development of human nephron-like structures in vitro fills a major gap in our ability to assess the effect of potential treatment on key kidney structures, opening up a wide range of possibilities to improve clinical translation.

4 December 2018 in eLife
Verified
Journal Article
Open access
MRMario Ruiz
Mario Ruiz
RBRakesh Bodhicharla
Rakesh Bodhicharla
ESEmma Svensk
Emma Svensk
RDRanjan Devkota
Ranjan Devkota
KBKiran Busayavalasa
Kiran Busayavalasa
MPMarc Pilon
Marc Pilon
Dietary fatty acids are the main building blocks for cell membranes in animals, and mechanisms must therefore exist that compensate for dietary variations. We isolated C. elegans mutants that improved tolerance to dietary saturated fat in a sensitized genetic background, including eight alleles of the novel gene fld-1 that encodes a homolog of the human TLCD1 and TLCD2 transmembrane proteins. FLD-1 is localized on plasma membranes and acts by limiting the levels of highly membrane-fluidizing long-chain polyunsaturated fatty acid-containing phospholipids. Human TLCD1/2 also regulate membrane fluidity by limiting the levels of polyunsaturated fatty acid-containing membrane phospholipids. FLD-1 and TLCD1/2 do not regulate the synthesis of long-chain polyunsaturated fatty acids but rather limit their incorporation into phospholipids. We conclude that inhibition of FLD-1 or TLCD1/2 prevents lipotoxicity by allowing increased levels of membrane phospholipids that contain fluidizing long-chain polyunsaturated fatty acids.

1 September 2018 in Biochemical Pharmacology
Verified
Journal Article
Closed access
AKAlexander J. Kvist
Alexander J. Kvist
KKKajsa P. Kanebratt
Kajsa P. Kanebratt
AWAnna Walentinsson
Anna Walentinsson
HPHenrik Palmgren
Henrik Palmgren
MOMatthew O'Hara
Matthew O'Hara
TATommy B. Andersson
Tommy B. Andersson